These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23378338)

  • 1. Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.
    Croucher DR; Hochgräfe F; Zhang L; Liu L; Lyons RJ; Rickwood D; Tactacan CM; Browne BC; Ali N; Chan H; Shearer R; Gallego-Ortega D; Saunders DN; Swarbrick A; Daly RJ
    Cancer Res; 2013 Mar; 73(6):1969-80. PubMed ID: 23378338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
    Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
    J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
    Zagozdzon R; Bougeret C; Fu Y; Avraham HK
    Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
    Anderson LR; Sutherland RL; Butt AJ
    Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
    Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
    Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
    Karam M; Legay C; Auclair C; Ricort JM
    Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
    Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
    Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
    Iqbal MS; Tsuyama N; Obata M; Ishikawa H
    Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L; Xiang B; Muthuswamy SK
    Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis.
    Bennett HL; Brummer T; Jeanes A; Yap AS; Daly RJ
    Oncogene; 2008 Apr; 27(19):2693-704. PubMed ID: 17998934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.
    Choi YL; Bocanegra M; Kwon MJ; Shin YK; Nam SJ; Yang JH; Kao J; Godwin AK; Pollack JR
    Cancer Res; 2010 Mar; 70(6):2296-306. PubMed ID: 20215510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.